Additionally, we identified clinical features and inflammatory markers correlated with miR-155-5p levels and described a model through which the combination of miR-155-5p with IL-8, Leptin and RAGE may be useful to individuate OB patients at higher risk of developing DM2. The gene discussed is CXCL8; the disease is myotonic dystrophy type 2.